Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study.
文献类型：期刊论文
| 作者 | Bachy, Emmanuel; Savage, Kerry J.; Huang, Huiqiang; Kwong, Yok-Lam; Gritti, Giuseppe; Zhang, Qingyuan; Liberati, Anna Marina; Cao, Junning; Yang, Haiyan; Hao, Siguo |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2022-06-01 |
| 卷号 | 40 |
| ISSN号 | 0732-183X |
| 资助项目 | BeiGene USA, Inc. |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| WOS记录号 | WOS:000863680302014 |
| 资助机构 | BeiGene USA, Inc. |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129811]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.BC Canc, Dept Med Oncol, Vancouver, BC, Canada 2.Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China 3.Osped Maggiore Parma, Ematol Ctr Trapianti Midollo Osseo CTMO, Parma, Italy 4.Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China 5.Sichuan Univ, West China Hosp, Chengdu, Peoples R China 6.Beijing Hosp, Beijing, Peoples R China 7.Beigene Co Ltd, Shanghai, Peoples R China 8.Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy 9.Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China 10.Tianjin Med Univ, Canc Inst Hosp, Tianjin, Peoples R China |
| 推荐引用方式 GB/T 7714 | Bachy, Emmanuel,Savage, Kerry J.,Huang, Huiqiang,et al. Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study.[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40. |
| APA | Bachy, Emmanuel.,Savage, Kerry J..,Huang, Huiqiang.,Kwong, Yok-Lam.,Gritti, Giuseppe.,...&Zinzani, Pier Luigi.(2022).Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study..JOURNAL OF CLINICAL ONCOLOGY,40. |
| MLA | Bachy, Emmanuel,et al."Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study.".JOURNAL OF CLINICAL ONCOLOGY 40(2022). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。